22 reports of this reaction
3.3% of all HYPERICUM PERFORATUM reports
#2 most reported adverse reaction
ANXIETY is the #2 most commonly reported adverse reaction for HYPERICUM PERFORATUM, manufactured by Energique, Inc. There are 22 FDA adverse event reports linking HYPERICUM PERFORATUM to ANXIETY. This represents approximately 3.3% of all 666 adverse event reports for this drug.
Patients taking HYPERICUM PERFORATUM who experience anxiety should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ANXIETY is moderately reported among HYPERICUM PERFORATUM users, representing a notable but not dominant share of adverse events.
In addition to anxiety, the following adverse reactions have been reported for HYPERICUM PERFORATUM:
The following drugs have also been linked to anxiety in FDA adverse event reports:
ANXIETY has been reported as an adverse event in 22 FDA reports for HYPERICUM PERFORATUM. This does not prove causation, but indicates an association observed in post-market surveillance data.
ANXIETY accounts for approximately 3.3% of all adverse event reports for HYPERICUM PERFORATUM, making it one of the most commonly reported side effect.
If you experience anxiety while taking HYPERICUM PERFORATUM, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.